United Therapeutics CEO Martine Rothblatt disposes of 9,595 common shares worth $4.98 million

Reuters2026/08/06 20:35

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

United Therapeutics Chairperson and CEO Martine A. Rothblatt exercised stock options for 9,500 shares at USD 135.42 on Aug. 5.
The related trust sold 9,494 shares in multiple trades, with reported prices ranging from USD 502.29 to USD 524.59.
Trust holdings ended the day at 324,443 shares of common stock.
The trust held 198,910 stock options following the transaction.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. United Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001106578-26-000114), on August 06, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

United Therapeutics CEO Martine Rothblatt disposes of 9,595 common shares worth $4.98 million

You may also like

Crypto prices